Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
Immunotherapy is a clinically validated treatment for many cancers to boost the immune system against tumor growth and dissemination. Several strategies are used to harness immune cells: monoclonal antibodies against tumor antigens, immune checkpoint inhibitors, vaccination, adoptive cell therapies...
Main Authors: | Valeria Mollica Poeta, Matteo Massara, Arianna Capucetti, Raffaella Bonecchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00379/full |
Similar Items
-
Corrigendum: ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology
by: Ornella Bonavita, et al.
Published: (2017-05-01) -
Multiple Roles for Chemokines in Neutrophil Biology
by: Arianna Capucetti, et al.
Published: (2020-07-01) -
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
by: Dina Morein, et al.
Published: (2020-06-01) -
Duffy Antigen Receptor for Chemokines (DARC) and its Involvement in Patterning and Control of Inflammatory Chemokines
by: Igor eNovitzky-Basso, et al.
Published: (2012-08-01) -
Neutrophils in Gliomas
by: Matteo Massara, et al.
Published: (2017-10-01)